» Articles » PMID: 20185796

A Novel Mitochondrial K(ATP) Channel Assay

Overview
Journal Circ Res
Date 2010 Feb 27
PMID 20185796
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Rationale: The mitochondrial ATP sensitive potassium channel (mK(ATP)) is implicated in cardioprotection by ischemic preconditioning (IPC), but the molecular identity of the channel remains controversial. The validity of current methods to assay mK(ATP) activity is disputed.

Objective: We sought to develop novel methods to assay mK(ATP) activity and its regulation.

Methods And Results: Using a thallium (Tl(+))-sensitive fluorophore, we developed a novel Tl(+) flux based assay for mK(ATP) activity, and used this assay probe several aspects of mK(ATP) function. The following key observations were made. (1) Time-dependent run down of mK(ATP) activity was reversed by phosphatidylinositol-4,5-bisphosphate (PIP(2)). (2) Dose responses of mK(ATP) to nucleotides revealed a UDP EC(50) of approximately 20 micromol/L and an ATP IC(50) of approximately 5 micromol/L. (3) The antidepressant fluoxetine (Prozac) inhibited mK(ATP) (IC(50)=2.4 micromol/L). Fluoxetine also blocked cardioprotection triggered by IPC, but did not block protection triggered by a mK(ATP)-independent stimulus. The related antidepressant zimelidine was without effect on either mK(ATP) or IPC.

Conclusions: The Tl(+) flux mK(ATP) assay was validated by correlation with a classical mK(ATP) channel osmotic swelling assay (R(2)=0.855). The pharmacological profile of mK(ATP) (response to ATP, UDP, PIP(2), and fluoxetine) is consistent with that of an inward rectifying K(+) channel (K(IR)) and is somewhat closer to that of the K(IR)6.2 than the K(IR)6.1 isoform. The effect of fluoxetine on mK(ATP)-dependent cardioprotection has implications for the growing use of antidepressants in patients who may benefit from preconditioning.

Citing Articles

Cardiac overexpression of a mitochondrial SUR2A splice variant impairs cardiac function and worsens myocardial ischemia reperfusion injury in female mice.

Wexler A, Dooge H, El-Meanawy S, Santos E, Hacker T, Tewari A J Mol Cell Cardiol Plus. 2024; 9.

PMID: 39507427 PMC: 11539194. DOI: 10.1016/j.jmccpl.2024.100088.


Redox Regulation of Mitochondrial Potassium Channels Activity.

Lewandowska J, Kalenik B, Wrzosek A, Szewczyk A Antioxidants (Basel). 2024; 13(4).

PMID: 38671882 PMC: 11047711. DOI: 10.3390/antiox13040434.


Erucin Exerts Cardioprotective Effects on Ischemia/Reperfusion Injury through the Modulation of mitoKATP Channels.

Flori L, Montanaro R, Pagnotta E, Ugolini L, Righetti L, Martelli A Biomedicines. 2023; 11(12).

PMID: 38137502 PMC: 10740937. DOI: 10.3390/biomedicines11123281.


Mitochondrial Oxidative Stress Is the General Reason for Apoptosis Induced by Different-Valence Heavy Metals in Cells and Mitochondria.

Korotkov S Int J Mol Sci. 2023; 24(19).

PMID: 37833908 PMC: 10572412. DOI: 10.3390/ijms241914459.


HNO Protects the Myocardium against Reperfusion Injury, Inhibiting the mPTP Opening via PKCε Activation.

Mancardi D, Pagliaro P, Ridnour L, Tocchetti C, Miranda K, Juhaszova M Antioxidants (Basel). 2022; 11(2).

PMID: 35204265 PMC: 8869498. DOI: 10.3390/antiox11020382.


References
1.
Alekseev A, Hodgson D, Karger A, Park S, Zingman L, Terzic A . ATP-sensitive K+ channel channel/enzyme multimer: metabolic gating in the heart. J Mol Cell Cardiol. 2005; 38(6):895-905. PMC: 2736952. DOI: 10.1016/j.yjmcc.2005.02.022. View

2.
Watt S, Kular G, Fleming I, Downes C, Lucocq J . Subcellular localization of phosphatidylinositol 4,5-bisphosphate using the pleckstrin homology domain of phospholipase C delta1. Biochem J. 2002; 363(Pt 3):657-66. PMC: 1222518. DOI: 10.1042/0264-6021:3630657. View

3.
Nikitina E, Glazunov V . Involvement of K+-ATP-dependent channel in transport of monovalent thallium (Tl+) across the inner membrane of rat liver mitochondria. Dokl Biochem Biophys. 2004; 392:244-6. DOI: 10.1023/a:1026130527827. View

4.
Shim Y, Kersten J . Preconditioning, anesthetics, and perioperative medication. Best Pract Res Clin Anaesthesiol. 2008; 22(1):151-65. DOI: 10.1016/j.bpa.2007.08.003. View

5.
Auchampach J, Grover G, Gross G . Blockade of ischaemic preconditioning in dogs by the novel ATP dependent potassium channel antagonist sodium 5-hydroxydecanoate. Cardiovasc Res. 1992; 26(11):1054-62. DOI: 10.1093/cvr/26.11.1054. View